Twinning boosts excellence in cancer research – Information Centre – Research & Innovation

Elvera Bartels

If countries can’t coach significant-high quality research workers, they will wrestle to produce progressive cancer treatment options. An EU-funded task enabled four tutorial institutions to exchange workers and share finest techniques, resulting in a variety of vocation advancements and effective research grant apps. These will benefit citizens by the researchers’ growing capabilities to progress cancer treatment options.


© anttoniart #300552708, supply: 2021

Inspite of considerable medical advancements, cancer remains a key wellness burden. In numerous countries, the ailment ranks as the next most widespread induce of death, a point that carries on to push research into new diagnostic procedures and treatment options.

“The progress of immunotherapies (treatment options that aid your immune technique to battle cancer) and vaccines are places of biotechnology exactly where we have viewed a good deal of operate,” notes VACTRAIN task coordinator Maria Issagouliantis, direct researcher at Riga Stradins University (RSU) in Latvia. “There is a enormous amount of money of social, political and scientific need for development to be made in these places.”

A crucial obstacle even so is making sure that chopping-edge research – as very well as new therapeutic resources – are adequately disseminated. This is vital, mainly because if expertise remains locked in a number of labs and institutions, or a number of countries, then the likely added benefits are not able to be completely realised. A deficiency of institutional experience also suggests that younger scientists frequently feel compelled to total their scientific tests overseas, getting their experience with them.

Sharing expertise and knowledge

The EU-funded VACTRAIN task sought to address this obstacle by setting up up institutional experience. “This wasn’t a research task as this kind of,” points out Issagouliantis. “Our goal was not to develop and examination new cancer immunotherapies, or therapeutic vaccinations. Fairly, we desired to carry with each other experience from different countries, in buy to persuade far better health care performances, primarily in Latvia, but also in other places.”

To realize this, the EU-funded VACTRAIN task linked RSU, a single of Latvia’s foremost biomedicine and biotechnology centres, with other institutions throughout Europe. “The university offers enormous research likely and medical experience,” provides Issagouliantis. “This made RSU an great applicant for twinning.”

All through the task, connections have been made with two internationally renowned research institutions – the Office of Microbiology, Tumour and Cell Biology at the Karolinska Institute (KI) in Sweden, and the Office of Normal Biophysics at the University of Lodz in Poland.

“Both signify centres of excellence in the design, screening and clinical apps of a huge course of immunotherapeutics,” says Issagouliantis. The consortium was complemented by the Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology in Ukraine (KIEPOR). “Altogether, the twinning energy united four associates,” points out Issagouliantis. “Links amongst these institutions have been forged by workshops, laboratory classes and extensive workers exchanges.”

Marketing research experience

This sharing of ordeals and finest techniques assisted to establish up institutional experience, inspiring progressive observe-up initiatives. RSU for instance has fashioned a taskforce to develop modern nanomedicines, which has long gone on to gain vital research grants from the Latvian Council of Science.

In addition, a unique cross-border research network involving trainees and scientists from all four husband or wife institutions has been released, to sort a kind of nanomedicine progress chain. The network has successfully competed for research grants on the design and screening of DNA-centered nanomedicines that focus on cancer.

“I imagine that the affect of this task can be calculated by the point that three global grants have been won by consortia involving VACTRAIN members,” says Issagouliantis. “VACTRAIN has assisted to lay the groundwork for the progress of innovative research in Latvia.”

Straight a consequence of the twinning task, a single senior researcher gained their 1st European grant, for a task devoted to producing nanomedicines. Two postgraduates who worked on the task are currently completing their PhD scientific tests in the subject of cancer, with completion anticipated in 2021.

“All this experience will aid us to coach and preserve keep of highly experienced experts in the long term,” notes Issagouliantis. “This is vital for the progress and wellness of our nation. Of the 8 younger trainees who participated in the task, only a single has remaining to continue on their scientific tests overseas. Supplying vocation chances suggests we can retain experience.”

Last but not least, development can also be viewed in Issagouliantis’ possess vocation development. “I was promoted to the place of foremost scientist at RSU in 2018, which was renewed in 2020,” she concludes. “I also gained a two-yr grant for research into immunotherapy from the Latvian Science Fund for 2018-2020.”

Next Post

Les jumelages favorisent l'excellen... - Information Centre - Research & Innovation

Si les pays ne sont pas en mesure de previous un staff de recherche de qualité, ils auront des difficultés à proposer des traitements innovants contre le cancer. Un projet financé par l’UE a permis à quatre établissements universitaires d’échanger du staff et de partager leurs meilleures pratiques. Ces avancées […]